Microcyn® Technology

Electrolysed bladder rinse solution intended for use as
an adjunct in the treatment and prevention of urinary tract infection

Urinary tract infection, the most common nosocomial infection worldwide, comprises 40% of all
healthcare-associated infections & CAUTI represents 80% of this group.

Catheter-associated urinary tract infections are a growing area of concern.

Antibiotic resistance continues to rise and the effect of standard antimicrobial therapies are
hindered by the persistance of biofilms.

Urinary tract infections (UTIs) are responsible for nearly 10 million doctor visits each year.

Without new technology to manage bioburden and subsequent urinary tract infections:

“The world is heading towards a post-antibiotic era, in which common infections and minor
injuries, which have been treatable for decades, can once again kill.“

The use of a super oxidised solution is a new concept in UTI management.

This Bladder Rinse replicates a natural mechanism against pathogens: Foreign substances are removed and destroyed by a natural, non-antibiotic, physical process allowing it to remain non-cytotoxic and non-irritating.